These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32422323)

  • 1. Evaluation of neurological effects of cerium dioxide nanoparticles doped with different amounts of zirconium following inhalation exposure in mouse models of Alzheimer's and vascular disease.
    Wahle T; Sofranko A; Dekkers S; Miller MR; Heusinkveld HJ; Albrecht C; Cassee FR; Schins RPF
    Neurochem Int; 2020 Sep; 138():104755. PubMed ID: 32422323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of zirconium doping of cerium dioxide nanoparticles on pulmonary and cardiovascular toxicity and biodistribution in mice after inhalation.
    Dekkers S; Miller MR; Schins RPF; Römer I; Russ M; Vandebriel RJ; Lynch I; Belinga-Desaunay MF; Valsami-Jones E; Connell SP; Smith IP; Duffin R; Boere JAF; Heusinkveld HJ; Albrecht C; de Jong WH; Cassee FR
    Nanotoxicology; 2017 Aug; 11(6):794-808. PubMed ID: 28741972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer's disease.
    Hullmann M; Albrecht C; van Berlo D; Gerlofs-Nijland ME; Wahle T; Boots AW; Krutmann J; Cassee FR; Bayer TA; Schins RPF
    Part Fibre Toxicol; 2017 Aug; 14(1):35. PubMed ID: 28854940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subchronic dietary exposure to the engineered nanomaterials SiO
    Sofranko A; Wahle T; Kolling J; Heusinkveld HJ; Stahlmecke B; Rosenbruch M; Albrecht C; Schins RPF
    Part Fibre Toxicol; 2022 Mar; 19(1):23. PubMed ID: 35337343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of concentrated ambient ultrafine particulate matter on hallmarks of Alzheimer's disease in the 3xTgAD mouse model.
    Herr D; Jew K; Wong C; Kennell A; Gelein R; Chalupa D; Raab A; Oberdörster G; Olschowka J; O'Banion MK; Elder A
    Neurotoxicology; 2021 May; 84():172-183. PubMed ID: 33794265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective memory and behavioral alterations after ambient ultrafine particulate matter exposure in aged 3xTgAD Alzheimer's disease mice.
    Jew K; Herr D; Wong C; Kennell A; Morris-Schaffer K; Oberdörster G; O'Banion MK; Cory-Slechta DA; Elder A
    Part Fibre Toxicol; 2019 Nov; 16(1):45. PubMed ID: 31771615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis.
    Machhi J; Yeapuri P; Markovic M; Patel M; Yan W; Lu Y; Cohen JD; Hasan M; Abdelmoaty MM; Zhou Y; Xiong H; Wang X; Mosley RL; Gendelman HE; Kevadiya BD
    ACS Chem Neurosci; 2022 Apr; 13(8):1232-1244. PubMed ID: 35312284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerium oxide and barium sulfate nanoparticle inhalation affects gene expression in alveolar epithelial cells type II.
    Schwotzer D; Niehof M; Schaudien D; Kock H; Hansen T; Dasenbrock C; Creutzenberg O
    J Nanobiotechnology; 2018 Feb; 16(1):16. PubMed ID: 29463257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic Oxidative Stress, Inflammation and DNA Damage Following Pulmonary Exposure to Cerium Oxide Nanoparticles in a Rat Model of Vascular Injury.
    Nemmar A; Al-Salam S; Beegam S; Yuvaraju P; Ali BH
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice.
    Nemmar A; Al-Salam S; Beegam S; Yuvaraju P; Ali BH
    Int J Nanomedicine; 2017; 12():2913-2922. PubMed ID: 28435267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    Lee SH; Chen YH; Chien CC; Yan YH; Chen HC; Chuang HC; Hsieh HI; Cho KH; Kuo LW; Chou CC; Chiu MJ; Tee BL; Chen TF; Cheng TJ
    PLoS One; 2021; 16(8):e0254587. PubMed ID: 34437570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
    Ringland C; Schweig JE; Eisenbaum M; Paris D; Ait-Ghezala G; Mullan M; Crawford F; Abdullah L; Bachmeier C
    BMC Neurosci; 2021 May; 22(1):39. PubMed ID: 34034683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatments with a 5-HT
    Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
    Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.